Skip to main content
Equibles

BIOX · Bioceres Crop Solutions Corp. · Earnings Call Transcripts & Audio

Track BIOX — free

Use BIOX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BIOX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.42 -0.01 (-2.58%) At close · Sep 10
Rebalance outlook locked
Market Cap
$26.17M
Shares
63.82M

Bioceres Crop Solutions Corp. Earnings Call Transcripts

Quarterly earnings calls for Bioceres Crop Solutions Corp. (BIOX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼22.6% $48.74M $648,193 '21 Q2 21-02-11 · $127.33M $498,297 '23 Q1 22-11-10 ▲33.1% $92.49M $28.15M '23 Q3 23-05-11 · $107.33M −$1.71M '23 Q4 23-06-30 ▲50.9% $140.22M $108,449 '24 Q2 24-02-08 ▼9.2% $83.98M $9.26M '24 Q3 24-05-14 ▲15.5% $123.99M −$498,353 '24 Q4 24-06-30 ▼20% $93.29M −$6.37M '25 Q1 24-11-12 ▼29.5% $98.80M $143,535 '25 Q2 25-02-12 ▼27.9% $60.59M −$1.30M '25 Q3 25-05-21 ▼33.5% $82.43M −$47.89M '25 Q4 25-06-30 LATEST ▼16.8% $77.60M −$7.33M '26 Q1 25-11-13
Earnings call
FY26 · Q3
2026-05-12
Bioceres Crop Solutions Corp. (BIOX) Q3 2026 Earnings Call Transcript
Cautious tone Revenue decline across segments Noteholder litigation and Profarm foreclosure Financial performance and net loss
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-11-13
Bioceres Crop Solutions Corp. (BIOX) Q1 2026 Earnings Call Transcript
Positive tone Crop Protection segment performance Gross margin and profitability expansion Argentina macro and midterm elections
Revenue
$77.60M
▼ 16.8% YoY
Diluted EPS
$-0.12
Gross margin
46.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-06-30
Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript
Positive tone Revenue decline and segment performance Argentina demand and elections Profitability and margin expansion
Revenue
$82.43M*
▼ 33.5% YoY
Gross margin
34.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-05-21
Bioceres Crop Solutions Corp. (BIOX) Q3 2025 Earnings Call Transcript
Positive tone Geographic recovery outside Argentina Rinotec/Neovo EPA approval and launch Argentina market and seasonality
Revenue
$60.59M
▼ 27.9% YoY
Diluted EPS
$-0.02
▼ 115% YoY
Gross margin
39.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-02-12
Bioceres Crop Solutions Corp. (BIOX) Q2 2025 Earnings Call Transcript
Cautious tone Argentina market headwinds Seed business restructuring Geographic diversification
Revenue
$98.80M
▼ 29.5% YoY
Diluted EPS
$0.00
▲ 35.3% YoY
Gross margin
42.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-11-12
Bioceres Crop Solutions Corp. (BIOX) Q1 2025 Earnings Call Transcript
Balanced tone Argentina weather and crop season Geographic diversification and growth markets HB4 technology and regulatory approvals
Revenue
$93.29M
▼ 20% YoY
Diluted EPS
$-0.10
Gross margin
40.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-06-30
Bioceres Crop Solutions Corp. (BIOX) Q4 2024 Earnings Call Transcript
Positive tone HB4 soybean and wheat commercialization Record financial performance Crop Nutrition underperformance
Revenue
$123.99M*
▲ 15.5% YoY
Gross margin
38.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-05-14
Bioceres Crop Solutions Corp. (BIOX) Q3 2024 Earnings Call Transcript
Positive tone Brazil HB4 soy and bio-control Syngenta compensatory payment timing Argentina winter crops outlook
Revenue
$83.98M
▼ 9.2% YoY
Diluted EPS
$0.14
▼ 68.9% YoY
Gross margin
50.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-02-08
Bioceres Crop Solutions Corp. (BIOX) Q2 2024 Earnings Call Transcript
Confident tone HB4 wheat and soy progress Regulatory approvals (HB4, Rhino Tech) Brazil and broader destocking headwinds
Revenue
$140.22M
▲ 50.9% YoY
Diluted EPS
$0.00
Gross margin
36.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-06-30
Bioceres Crop Solutions Corp. (BIOX) Q4 2023 Earnings Call Transcript
Revenue
$107.33M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-05-11
Bioceres Crop Solutions Corp. (BIOX) Q3 2023 Earnings Call Transcript
Revenue
$92.49M
▲ 33.1% YoY
Diluted EPS
$0.45
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-11-10
Bioceres Crop Solutions Corp. (BIOX) Q1 2023 Earnings Call Transcript
Revenue
$127.33M
Diluted EPS
$0.01
Gross margin
40.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-30
Bioceres Crop Solutions Corp. (BIOX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q1
2021-11-10
Bioceres Crop Solutions Corp. (BIOX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-02-11
Bioceres Crop Solutions Corp. (BIOX) Q2 2021 Earnings Call Transcript
Revenue
$48.74M
▼ 22.6% YoY
Diluted EPS
$0.02
▼ 94.7% YoY
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-30
Bioceres Crop Solutions Corp. (BIOX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–16 of 16 earnings calls
Key facts CIK 1769484 CUSIP G1117K114 13F (30d) 19 filings 19 filers Visit website Investor relations